Anat Erdreich-Epstein - Publications

Affiliations: 
Neuroscience University of Southern California, Los Angeles, CA, United States 
Area:
Oncology

50 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Pathania AS, Ren X, Mahdi MY, Shackleford GM, Erdreich-Epstein A. GRK2 promotes growth of medulloblastoma cells and protects them from chemotherapy-induced apoptosis. Scientific Reports. 9: 13902. PMID 31554835 DOI: 10.1038/s41598-019-50157-5  0.32
2019 Kaneva K, Yeo KK, Hawes D, Ji J, Biegel JA, Nelson MD, Bluml S, Krieger MD, Erdreich-Epstein A. Rare Pediatric Invasive Gliofibroma Has BRAFV600E Mutation and Transiently Responds to Targeted Therapy Before Progressive Clonal Evolution. Jco Precision Oncology. 3. PMID 31179415 DOI: 10.1200/PO.18.00138  0.68
2019 Shackleford GM, Mahdi MY, Moats RA, Hawes D, Tran HC, Finlay JL, Hoang TQ, Meng EF, Erdreich-Epstein A. Continuous and bolus intraventricular topotecan prolong survival in a mouse model of leptomeningeal medulloblastoma. Plos One. 14: e0206394. PMID 30608927 DOI: 10.1371/journal.pone.0206394  0.68
2017 Erdreich-Epstein A, Singh AR, Joshi S, Vega FM, Guo P, Xu J, Groshen S, Ye W, Millard M, Campan M, Morales G, Garlich JR, Laird PW, Seeger RC, Shimada H, et al. Association of high microvessel αvβ3 and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126. Oncotarget. 8: 52193-52210. PMID 28881723 DOI: 10.18632/oncotarget.13386  0.68
2017 Xu J, Ren X, Pathania AS, Fernandez GE, Tran A, Zhang Y, Moats RA, Shackleford GM, Erdreich-Epstein A. PID1 increases chemotherapy-induced apoptosis in medulloblastoma and glioblastoma cells in a manner that involves NFκB. Scientific Reports. 7: 835. PMID 28400607 DOI: 10.1038/s41598-017-00947-6  0.68
2016 Torchia J, Golbourn B, Feng S, Ho KC, Sin-Chan P, Vasiljevic A, Norman JD, Guilhamon P, Garzia L, Agamez NR, Lu M, Chan TS, Picard D, de Antonellis P, Khuong-Quang DA, ... ... Erdreich-Epstein A, et al. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors. Cancer Cell. 30: 891-908. PMID 27960086 DOI: 10.1016/j.ccell.2016.11.003  0.44
2016 Erdreich-Epstein A, Singh AR, Joshi S, Vega FM, Guo P, Xu J, Groshen S, Ye W, Millard M, Campan M, Morales G, Garlich JR, Laird PW, Seeger RC, Shimada H, et al. Association of high microvessel αvβ3 and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126. Oncotarget. PMID 27907905 DOI: 10.18632/oncotarget.13386  0.68
2016 Shackleford GM, Shi XH, Swanson KS, Mahdi MY, Gonzalez-Gomez I, Asgharzadeh S, D'Apuzzo M, Erdreich-Epstein A, Moats RA. BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma. Plos One. 11: e0156907. PMID 27310018 DOI: 10.1371/journal.pone.0156907  0.68
2015 Xu J, Margol AS, Shukla A, Ren X, Finlay JL, Krieger MD, Gilles FH, Couch FJ, Aziz M, Fung ET, Asgharzadeh S, Barrett MT, Erdreich-Epstein A. Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi Anemia. Frontiers in Oncology. 5: 191. PMID 26380221 DOI: 10.3389/fonc.2015.00191  0.68
2015 Blüml S, Margol AS, Sposto R, Kennedy RJ, Robison NJ, Vali M, Hung LT, Muthugounder S, Finlay JL, Erdreich-Epstein A, Gilles FH, Judkins AR, Krieger MD, Dhall G, Nelson MD, et al. Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy. Neuro-Oncology. PMID 26254476 DOI: 10.1093/neuonc/nov097  0.68
2015 Weingart MF, Roth JJ, Hutt-Cabezas M, Busse TM, Kaur H, Price A, Maynard R, Rubens J, Taylor I, Mao XG, Xu J, Kuwahara Y, Allen SJ, Erdreich-Epstein A, Weissman BE, et al. Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target. Oncotarget. 6: 3165-77. PMID 25638158  0.68
2015 Kaur H, Hütt-Cabezas M, Weingart MF, Xu J, Kuwahara Y, Erdreich-Epstein A, Weissman BE, Eberhart CG, Raabe EH. The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity. Journal of Neuropathology and Experimental Neurology. 74: 177-85. PMID 25575139 DOI: 10.1097/NEN.0000000000000161  0.68
2015 Margol AS, Robison NJ, Gnanachandran J, Hung LT, Kennedy RJ, Vali M, Dhall G, Finlay JL, Erdreich-Epstein A, Krieger MD, Drissi R, Fouladi M, Gilles FH, Judkins AR, Sposto R, et al. Tumor-associated macrophages in SHH subgroup of medulloblastomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1457-65. PMID 25344580 DOI: 10.1158/1078-0432.CCR-14-1144  0.68
2015 Chakravadhanula M, Hampton CN, Chodavadia P, Ozols V, Zhou L, Catchpoole D, Xu J, Erdreich-Epstein A, Bhardwaj RD. Wnt pathway in atypical teratoid rhabdoid tumors. Neuro-Oncology. 17: 526-35. PMID 25246426 DOI: 10.1093/neuonc/nou229  0.68
2015 Xu J, Margol A, Asgharzadeh S, Erdreich-Epstein A. Pediatric brain tumor cell lines. Journal of Cellular Biochemistry. 116: 218-24. PMID 25211508 DOI: 10.1002/jcb.24976  0.68
2015 Xu J, Margol AS, Shukla A, Ren X, Finlay JL, Krieger MD, Gilles FH, Couch FJ, Aziz M, Fung ET, Asgharzadeh S, Barrett MT, Erdreich-Epstein A. Disseminated medulloblastoma in a child with germline BRCA2 6174delT mutation and without Fanconi anemia Frontiers in Oncology. 5. DOI: 10.3389/fonc.2015.00191  0.68
2014 Nandhu MS, Hu B, Cole SE, Erdreich-Epstein A, Rodriguez-Gil DJ, Viapiano MS. Novel paracrine modulation of Notch-DLL4 signaling by fibulin-3 promotes angiogenesis in high-grade gliomas. Cancer Research. 74: 5435-48. PMID 25139440 DOI: 10.1158/0008-5472.CAN-14-0685  0.68
2014 Antony R, Wong KE, Patel M, Olch AJ, McComb G, Krieger M, Gilles F, Sposto R, Erdreich-Epstein A, Dhall G, Gardner S, Finlay JL. A retrospective analysis of recurrent intracranial ependymoma. Pediatric Blood & Cancer. 61: 1195-201. PMID 24615997 DOI: 10.1002/pbc.24996  0.68
2014 Lee JS, Xiao J, Patel P, Schade J, Wang J, Deneen B, Erdreich-Epstein A, Song HR. A novel tumor-promoting role for nuclear factor IA in glioblastomas is mediated through negative regulation of p53, p21, and PAI1. Neuro-Oncology. 16: 191-203. PMID 24305710 DOI: 10.1093/neuonc/not167  0.68
2014 Erdreich-Epstein A, Robison N, Ren X, Zhou H, Xu J, Davidson TB, Schur M, Gilles FH, Ji L, Malvar J, Shackleford GM, Margol AS, Krieger MD, Judkins AR, Jones DT, et al. PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 827-36. PMID 24300787 DOI: 10.1158/1078-0432.CCR-13-2053  0.68
2012 Ren X, Xu J, Cooper JP, Kang MH, Erdreich-Epstein A. c-Abl is an upstream regulator of acid sphingomyelinase in apoptosis induced by inhibition of integrins αvβ3 and αvβ5. Plos One. 7: e42291. PMID 22879933 DOI: 10.1371/journal.pone.0042291  0.68
2012 Ridgway LD, Wetzel MD, Ngo JA, Erdreich-Epstein A, Marchetti D. Heparanase-induced GEF-H1 signaling regulates the cytoskeletal dynamics of brain metastatic breast cancer cells. Molecular Cancer Research : McR. 10: 689-702. PMID 22513363 DOI: 10.1158/1541-7786.MCR-11-0534  0.68
2012 Davidson TB, Sanchez-Lara PA, Randolph LM, Krieger MD, Wu SQ, Panigrahy A, Shimada H, Erdreich-Epstein A. Microdeletion del(22)(q12.2) encompassing the facial development-associated gene, MN1 (meningioma 1) in a child with Pierre-Robin sequence (including cleft palate) and neurofibromatosis 2 (NF2): a case report and review of the literature. Bmc Medical Genetics. 13: 19. PMID 22436304 DOI: 10.1186/1471-2350-13-19  0.68
2012 Xu J, Erdreich-Epstein A, Gonzalez-Gomez I, Melendez EY, Smbatyan G, Moats RA, Rosol M, Biegel JA, Reynolds CP. Novel cell lines established from pediatric brain tumors. Journal of Neuro-Oncology. 107: 269-80. PMID 22120608 DOI: 10.1007/s11060-011-0756-5  0.68
2012 Gozali AE, Britt B, Shane L, Gonzalez I, Gilles F, McComb JG, Krieger MD, Lavey RS, Shlien A, Villablanca JG, Erdreich-Epstein A, Dhall G, Jubran R, Tabori U, Malkin D, et al. Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: the Children's Hospital Los Angeles (CHLA) experience, 1991-2010. Pediatric Blood & Cancer. 58: 905-9. PMID 21990040 DOI: 10.1002/pbc.23349  0.68
2011 Chaitanya GV, Cromer WE, Wells SR, Jennings MH, Couraud PO, Romero IA, Weksler B, Erdreich-Epstein A, Mathis JM, Minagar A, Alexander JS. Gliovascular and cytokine interactions modulate brain endothelial barrier in vitro. Journal of Neuroinflammation. 8: 162. PMID 22112345 DOI: 10.1186/1742-2094-8-162  0.68
2011 Parekh C, Jubran R, Erdreich-Epstein A, Panigrahy A, Bluml S, Finlay J, Dhall G. Treatment of children with recurrent high grade gliomas with a bevacizumab containing regimen. Journal of Neuro-Oncology. 103: 673-80. PMID 21038110 DOI: 10.1007/s11060-010-0444-x  0.68
2010 Song HR, Gonzalez-Gomez I, Suh GS, Commins DL, Sposto R, Gilles FH, Deneen B, Erdreich-Epstein A. Nuclear factor IA is expressed in astrocytomas and is associated with improved survival. Neuro-Oncology. 12: 122-32. PMID 20150379 DOI: 10.1093/neuonc/nop044  0.68
2010 Xu J, Millard M, Ren X, Cox OT, Erdreich-Epstein A. c-Abl mediates endothelial apoptosis induced by inhibition of integrins alphavbeta3 and alphavbeta5 and by disruption of actin. Blood. 115: 2709-18. PMID 20124512 DOI: 10.1182/blood-2009-05-223776  0.68
2010 Xiong G, Husseiny MI, Song L, Erdreich-Epstein A, Shackleford GM, Seeger RC, Jäckel D, Hensel M, Metelitsa LS. Novel cancer vaccine based on genes of Salmonella pathogenicity island 2. International Journal of Cancer. Journal International Du Cancer. 126: 2622-34. PMID 19824039 DOI: 10.1002/ijc.24957  0.68
2009 Rosol M, Harutyunyan I, Xu J, Melendez E, Smbatyan G, Finlay JL, Krieger MD, Gonzalez-Gomez I, Reynolds CP, Nelson MD, Erdreich-Epstein A, Blüml S. Metabolism of orthotopic mouse brain tumor models. Molecular Imaging. 8: 199-208. PMID 19728974 DOI: 10.2310/7290.2009.00019  0.68
2009 Butturini AM, Jacob M, Aguajo J, Vander-Walde NA, Villablanca J, Jubran R, Erdreich-Epstein A, Marachelian A, Dhall G, Finlay JL. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome. Cancer. 115: 2956-63. PMID 19402050 DOI: 10.1002/cncr.24341  0.68
2007 Rosenne E, Shakhar G, Melamed R, Schwartz Y, Erdreich-Epstein A, Ben-Eliyahu S. Inducing a mode of NK-resistance to suppression by stress and surgery: a potential approach based on low dose of poly I-C to reduce postoperative cancer metastasis. Brain, Behavior, and Immunity. 21: 395-408. PMID 17240115 DOI: 10.1016/j.bbi.2006.12.002  0.68
2007 Finlay JL, Erdreich-Epstein A, Packer RJ. Progress in the treatment of childhood brain tumors: no room for complacency. Pediatric Hematology and Oncology. 24: 79-84. PMID 17130118 DOI: 10.1080/08880010601001073  0.68
2006 Erdreich-Epstein A, Ganguly AK, Shi XH, Zimonjic DB, Shackleford GM. Androgen inducibility of Fgf8 in Shionogi carcinoma 115 cells correlates with an adjacent t(5;19) translocation. Genes, Chromosomes & Cancer. 45: 169-81. PMID 16252261 DOI: 10.1002/gcc.20280  0.68
2005 Sohara Y, Shimada H, Minkin C, Erdreich-Epstein A, Nolta JA, DeClerck YA. Bone marrow mesenchymal stem cells provide an alternate pathway of osteoclast activation and bone destruction by cancer cells. Cancer Research. 65: 1129-35. PMID 15734993 DOI: 10.1158/0008-5472.CAN-04-2853  0.68
2005 Erdreich-Epstein A, Tran LB, Cox OT, Huang EY, Laug WE, Shimada H, Millard M. Endothelial apoptosis induced by inhibition of integrins alphavbeta3 and alphavbeta5 involves ceramide metabolic pathways. Blood. 105: 4353-61. PMID 15705795 DOI: 10.1182/blood-2004-08-3098  0.68
2004 Jubran RF, Erdreich-Epstein A, Butturini A, Murphree AL, Villablanca JG. Approaches to treatment for extraocular retinoblastoma: Children's Hospital Los Angeles experience. Journal of Pediatric Hematology/Oncology. 26: 31-4. PMID 14707710 DOI: 10.1097/00043426-200401000-00011  0.68
2003 Stins MF, Pearce D, Di Cello F, Erdreich-Epstein A, Pardo CA, Sik Kim K. Induction of intercellular adhesion molecule-1 on human brain endothelial cells by HIV-1 gp120: role of CD4 and chemokine coreceptors. Laboratory Investigation; a Journal of Technical Methods and Pathology. 83: 1787-98. PMID 14691297 DOI: 10.1097/01.LAB.0000107008.13321.C8  0.68
2003 Perelman N, Selvaraj SK, Batra S, Luck LR, Erdreich-Epstein A, Coates TD, Kalra VK, Malik P. Placenta growth factor activates monocytes and correlates with sickle cell disease severity. Blood. 102: 1506-14. PMID 12714517 DOI: 10.1182/blood-2002-11-3422  0.68
2002 Erdreich-Epstein A, Tran LB, Bowman NN, Wang H, Cabot MC, Durden DL, Vlckova J, Reynolds CP, Stins MF, Groshen S, Millard M. Ceramide signaling in fenretinide-induced endothelial cell apoptosis. The Journal of Biological Chemistry. 277: 49531-7. PMID 12388538 DOI: 10.1074/jbc.M209962200  0.68
2002 Erdreich-Epstein A, Monforte HL, Lavey RS, Joshi S, Phillips JD, Villablanca JG. Successful multimodality therapy of recurrent multifocal juvenile granulosa cell tumor of the ovary. Journal of Pediatric Hematology/Oncology. 24: 229-33. PMID 11990313 DOI: 10.1097/00043426-200203000-00015  0.68
2001 Isogai C, Laug WE, Shimada H, Declerck PJ, Stins MF, Durden DL, Erdreich-Epstein A, DeClerck YA. Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin Cancer Research. 61: 5587-5594. PMID 11454712  0.68
2000 Erdreich-Epstein A, Shimada H, Groshen S, Liu M, Metelitsa LS, Kim KS, Stins MF, Seeger RC, Durden DL. Integrins α(v)β3 and α(v)β5 are expressed by endothelium of high- risk neuroblastoma and their inhibition is associated with increased endogenous ceramide Cancer Research. 60: 712-721. PMID 10676658  0.68
1999 Park RK, Erdreich-Epstein A, Liu M, Izadi KD, Durden DL. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase Journal of Immunology. 163: 6023-6034. PMID 10570290  0.68
1999 Erdreich-Epstein A, Liu M, Kant AM, Izadi KD, Nolta JA, Durden DL. Cbl functions downstream of Src kinases in FcγRI signaling in primary human macrophages Journal of Leukocyte Biology. 65: 523-534. PMID 10204582  0.68
1998 Izadi KD, Erdreich-Epstein A, Liu Y, Durden DL. Characterization of Cbl-Nck and Nck-Pak1 interactions in myeloid FcγRII signaling Experimental Cell Research. 245: 330-342. PMID 9851874 DOI: 10.1006/excr.1998.4259  0.68
1998 Erdreich-Epstein A, Shackleford GM. Differential expression of Wnt genes in normal and flat variants of PC12 cells, a cell line responsive to ectopic Wnt1 expression Growth Factors. 15: 149-158. PMID 9505170  0.68
1997 Erdreich-Epstein A, Liu M, Liu Y, Durden DL. Protein tyrosine phosphatase inhibitors in FcγRI-induced myeloid oxidant signaling Experimental Cell Research. 237: 288-295. PMID 9434624 DOI: 10.1006/excr.1997.3795  0.68
1992 Sakamoto K, Erdreich-Epstein A, Declerck Y, Coates T. Prolonged clinical response to vincristine treatment in two patients with idiopathic hypereosinophilic syndrome Journal of Pediatric Hematology/Oncology. 14: 348-351. PMID 1456402  0.68
Show low-probability matches.